Article Figures & Data
Figures
- Figure 1.
Differences in Primary Efficacy Endpoint (Change in HbA1C).
Reprinted from The Lancet. Volume 375, Issue 9724, Pratley RE et al, Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycemic control with metformin: a 26-week, randomized, parallel-group, open-label trial, pages 1447–1456, Copyright 2010, with permission from Elsevier.
- Figure 2.
Proportion of Participants Achieving HbA1C Target Values.
Reprinted from The Lancet. Volume 375, Issue 9724, Pratley RE et al, Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycemic control with metformin: a 26-week, randomized, parallel-group, open-label trial, pages 1447–1456, Copyright 2010, with permission from Elsevier.
- Figure 3.
Change in Body Weight.
Reprinted from The Lancet. Volume 375, Issue 9724, Pratley RE et al, Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycemic control with metformin: a 26-week, randomized, parallel-group, open-label trial, pages 1447–1456, Copyright 2010, with permission from Elsevier.
Tools
Table of contents
Cited By...
- No citing articles found.